Lobbying

Minimed Group MMED's latest lobbying report covers Q2 2026, at $110K. Its first report covers Q1 2026; the issues it reports most are Health Issues and Medicare/Medicaid.

Minimed GroupMMED

Minimed Group stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$190K
Last 3 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2026
The first quarter a report named it

Lobbying by quarter

Minimed Group lobbying by quarter
Minimed Group lobbying by quarter
QuarterAmountReports
Q1 2026$80K1
Q2 2026$110K2
Q3 2026$00

By issue

  • Health issues$175K · 3 reports
  • Medicare and Medicaid$15K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES3 reports
  • SENATE3 reports
  • Office of Management & Budget (OMB)2 reports

Firms it paid

Firm
In-houseMinimed Group$160K2 quarters
Mehlman Consulting$30K1 quarters

Former officials lobbying for it

Former position
ELI KOGANRep. Joe Crowley, Senior Legislative Assistant, Legislative Assistant, Legislative CorrespondentQ1 2026

Lobbying reports

Filed by
07/20for Q2In-house$80K
07/20for Q2Mehlman Consulting$30K
06/16for Q2Mehlman ConsultingUnder $5,000
04/20for Q1In-house$80K
04/17for Q1In-houseUnder $5,000